Quantcast

Latest Kidney transplantation Stories

2014-06-17 23:04:17

Preliminary Results Show Herbal Extract NT619 Significantly Reduced Hypertension, High Blood Sugar, in Pre-Clinical Study Pittsburgh, Pa (PRWEB) June 17, 2014 A two-year, $300,000 DSF Charitable Foundation grant to Allegheny General Hospital (AGH) researchers, supporting the study of pancreatic transplantation and the use of herbal medication for the treatment of type 2 diabetes, is already showing intriguing results in the treatment of hypertension and high blood sugar in a pre-clinical...

2014-06-12 23:14:32

Dr. Prakash Rao accepts award from the National Kidney Registry for the work of NJ Sharing Network Transplant Laboratory. New Providence, NJ (PRWEB) June 12, 2014 NJ Sharing Network’s state-of-the-art lab has received the National Kidney Registry’s “Excellence in Teamwork Award” for its participation in the longest kidney swap of 2013. NJ Sharing Network participated in “Chain 221,” the second longest chain in the history of kidney transplants with 56 participants, through...

2014-06-09 20:22:38

Bill introduced by Representatives Tom Marino and John Lewis would improve lives of kidney patients WASHINGTON, June 9, 2014 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP) today praised Representatives Tom Marino (R-PA) and John Lewis (D-GA) for introducing "The Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4814)," a bill supporting improvements in the research, treatment and care of chronic kidney disease to benefit more than 400,000 Americans...

2014-06-04 15:42:09

Johns Hopkins Bloomberg School of Public Health A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that new therapies for kidney disease could be developed more quickly by revising the definition of kidney disease progression used during clinical trials. If adopted, the new definition could shorten the length of some clinical trials and also potentially encourage more clinical trials in kidney disease. The findings will be published in the June...

2014-06-03 16:25:04

HORSHOLM, Denmark, June 3, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the hiring of senior level management in preparation for potential U.S. commercialization of Envarsus(®) XR (tacrolimus extended-release tablets) an investigational new drug under FDA review for the prevention of organ rejection in adult kidney transplant patients. Key points: -- Envarsus( )XR is an extended release formulation of tacrolimus being designed for once-daily...

2014-05-29 12:28:41

WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ -- On May 30(th), nephrologists and kidney patients from across the country will convene in Washington to participate in the Renal Physicians Association's (RPA) annual Capitol Hill Day. Coordinated in collaboration with the American Association of Kidney Patients (AAKP), RPA's Capitol Hill day offers kidney patients and nephrologists the opportunity to advocate on issues impacting the delivery of effective and appropriate kidney disease...

2014-05-22 23:16:21

New book tells of an extraordinary comeback from kidney failure to good health. London (PRWEB) May 22, 2014 Adeleke Eniola Oyenusi’s recovery from kidney failure inspired him to write his new book “Living a Normal and Healthy Life after Renal (Kidney) Failure” (published by Trafford Publishing) to encourage and educate other renal patients with little or no knowledge about the condition. “I asked my wife to quickly rush me to the hospital when I became breathless and feared I...

2014-05-22 04:21:28

HORSHOLM, Denmark, May 22, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Envarsus® for the prevention of organ rejection in adult transplant patients in the European Union (EU). The positive opinion is for both kidney and liver transplant recipients and includes both the...

2014-05-01 12:32:14

WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- Today RPA joins 14 other kidney organizations to promote changes in kidney care on Capitol Hill. Participants in Kidney Community Advocacy Day represent health professionals and kidney patients and will meet with elected officials and their staff to discuss issues that will improve the treatment and quality of life for millions of Americans: increasing federal investment in kidney research, and extending lifetime immunosuppressive drug...

2014-04-29 23:12:43

The heart and liver transplantation programs at Allegheny General Hospital (AGH), part of the Allegheny Health Network, are the region’s best in patient care quality, according to the latest report by the Scientific Registry of Transplant Recipients (SRTR). Pittsburgh, PA (PRWEB) April 29, 2014 The heart and liver transplantation programs at Allegheny General Hospital (AGH), part of the Allegheny Health Network, are the region’s best in patient care quality, according to the latest...


Latest Kidney transplantation Reference Libraries

2011-01-05 16:14:54

The BK virus, a member of the polyomavirus family, has no major consequences of infected except with those that are immunocomprimised or immunosuppressed. The virus was first isolated in 1971 from the urine sample of a renal transplant patient whose initials were B.K. Similar in genome sequences to the JCV virus they are most easily identified and differentiated from each other through serological tests using specific antibodies or through PCR based genotyping approach. Most people are...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'